10 Best Up and Coming Stocks To Buy According to Analysts

Page 9 of 9

1. Day One Biopharmaceuticals Inc. (NASDAQ:DAWN)

Average Upside Potential as of November 26: 190.39%

Number of Hedge Fund Holders: 34

Day One Biopharmaceuticals Inc. (NASDAQ:DAWN) is a clinical-stage biopharmaceutical company that develops targeted therapies for patients with genomically defined cancers. It focuses on creating treatments for specific cancer types, including its lead product candidate, tovorafenib, which is an oral medication under the brand name OJEMDA. It is a treatment for pediatric low-grade glioma (pLGG), a type of brain or spinal cord tumor that affects children.

A major milestone for the company was the FDA approval of OJEMDA in April 2024. This approval is significant as it offers a new and effective treatment option for pLGG, a disease that has historically lacked targeted therapies. OJEMDA has shown promising results in clinical trials, demonstrating its ability to improve the quality of life for young patients with pLGG. Driven by these factors, the company was able to generate $93.76 million in Q3 2024.

The company achieved $20.1 million in net product revenue for OJEMDA in the third quarter of 2024, a significant increase over the previous quarter. This growth is attributed to increased prescriptions, high patient persistence, expanding prescriber base, and favorable payer coverage. With the continued momentum of OJEMDA and the advancement of its pipeline, Day One Biopharmaceuticals Inc. (NASDAQ:DAWN) is well-positioned for future growth and value creation for its shareholders.

While we acknowledge the growth potential of Day One Biopharmaceuticals Inc. (NASDAQ:DAWN), our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than DAWN but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9